Skip to main content

2023 ERS Congress

ERS 2023 Supported Content

European Respiratory Society (ERS) 2023: In-depth report

This in-depth report provides an overview of the latest advances in the diagnosis, treatment and management of chronic obstructive pulmonary disease and interstitial lung disease presented at ERS 2023.

Supported by: F. Hoffmann-La Roche Ltd.

Developed by: Springer Healthcare

Pulmonary rehabilitation does not improve BLVR-EBV outcomes

Pulmonary rehabilitation offers no benefit in outcomes for patients already undergoing bronchoscopic lung volume reduction using endobronchial valves.

Cardiac MRI for risk stratification of PAH

25-09-2023 Pulmonary Hypertension News

A new risk stratification approach allows physicians to estimate 1-year mortality for newly diagnosed patients with pulmonary arterial hypertension based on cardiac MRI.

Feasibility of local care for pulmonary fibrosis patients

Cooperation between local hospitals and specialized centers leads to better care for patients with pulmonary fibrosis, is less environmentally damaging.

Triple therapy beneficial for COPD patients with ECG abnormalities

COPD patients with ECG abnormalities are at greater risk of exacerbations, cardiovascular problems, and death. Triple therapy with fluticasone, umeclidinium, and vilanterol appears beneficial.

Inhaled idrevloride in hypertonic saline may benefit patients with primary ciliary dyskinesia

People with primary ciliary dyskinesia may show improved lung function after treatment with inhaled idrevloride in hypertonic saline.

Smoking cessation program integrated with lung cancer screening

A stop-smoking intervention, offered in combination with a lung cancer screening program, is proving successful in encouraging people to quit smoking.

Effect of the infant microbiome on wheezing at preschool age

Results from the Australian Barwon Infant Study show children who have a more mature gastrointestinal microbiome at age 1 are less likely to suffer from atopic wheeze at age 4.

Automatic oxygen delivery leads to better control but not earlier discharge

COPD patients who are automatically administered oxygen during hospitalization for exacerbation spend more time in normoxemia than patients in whom oxygen delivery is manually regulated.

Benralizumab may still lead to remission even in second year of treatment

25-09-2023 Bronchial Asthma News

Up to a third of patients with severe eosinophilic asthma who do not achieve clinical remission after 1 year of treatment with benralizumab still achieve remission in the second year.

Unlock your free access to coverage of the ERS International Congress 2023

Breath test distinguishes people with and without asthma

25-09-2023 Bronchial Asthma News

A deep neural network has been developed to distinguish between patients with and without asthma through breath test measurement data.

Sputum colour for prediction of bronchiectasis prognosis

25-09-2023 Bronchiectasis News

Sputum colour in patients with bronchiectasis could be considered a simple biomarker, providing information about long-term prognosis.

22-09-2023 Lung Transplantation News

Tacrolimus superior to ciclosporin for reducing chronic lung allograft dysfunction

ScanCLAD study findings support the use of once-per-day tacrolimus over twice daily ciclosporin for immunosuppression after lung transplantation.

Stay up to date with more from Springer Medicine

At a glance: The CheckMate lung cancer trials

Lung Cancer Clinical Trial Summary

A round-up of the CheckMate trials evaluating the PD-1 inhibitor nivolumab in non-small-cell lung cancer and small-cell lung cancer.

Biomarker-driven management of NSCLC (Link opens in a new window)


Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

1.0 AMA PRA Category 1 Credit(s)™

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.

Digital treatment map for ALK- and ROS1-mutated NSCLC (Link opens in a new window)

NSCLC Independent Medical Education

Practical, expert-led digital map designed to guide treatment of ALK- and ROS1-mutation positive NSCLC.

Supported by:
  • Pfizer

Further Reading

Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study

Open Access Nosocomial Pneumonia Original Article

Antibiotic resistance is a major global health concern impacting both medical costs and mortality rates [ 1 ]. In particular, resistance to carbapenems in Acinetobacter baumannii exceeds 70% in Southern and Eastern European regions, including Italy …

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields


Lung cancer represents one of the leading causes of cancer-related deaths, but substantial advances have been made in enhancing the ways in which lung cancers are histologically identified and molecularly profiled. As a result, several targeted …

Clinical characteristics, imaging findings, management, and outcomes of patients with scimitar syndrome at a tertiary referral healthcare center in Colombia

Open Access Computed Tomography Original Paper

Scimitar Syndrome is part of a complex spectrum of congenital cardiovascular anomalies related to anomalous pulmonary venous return. Depending on the extent of involvement, treatment can be either expectant or surgical. Prognosis and survival have …

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

Open Access Pleural Effusion Research

Dasatinib is one of the second generation tyrosine kinase inhibitors (TKI) which is approved for the treatment of patients with chronic phase CML (CP-CML) both in the front line and in the second line setting. Pleural effusion (PE) is a unique …